EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1β treatment

Abstract

Tendinopathy is accompanied by inflammation, tendon matrix degradation, or both. Inflammatory cytokine IL-1beta, which is a potent inflammatory mediator, is likely present within the tendon. The purpose of this study was to determine the biological impact of IL-1beta on tendon fibroblasts by assessing the expression of cPLA(2), COX-2, PGE(2) and its receptors (EPs), collagen type-I, and MMPs. We also studied the role of the p38 MAPK pathway in IL-1beta-induced catabolic effects. We found that IL-1beta increased the expression levels of cPLA(2) and COX-2, and also increased the secretion of PGE(2). Induction of MMPs, such as MMP-1 and MMP-3 at the mRNA level, was also observed after stimulation with IL-1beta. Furthermore, the presence of IL-1beta significantly decreased the level of collagen type-I mRNA in tendon fibroblasts. These effects were found to be mediated by selective upregulation of EP(4) receptor, which is a member of G-protein-coupled receptor that transduces the PGE(2) signal. Blocking EP(4) receptor by a specific chemical inhibitor abolished IL-1beta-induced catabolic effects. These results suggest that IL-1beta-induced catabolic action on tendon fibroblasts occurs via the upregulation of two key inflammatory mediators, cPLA(2) and COX-2, which are responsible for the synthesis of PGE(2). IL-1beta further stimulates the expression of EP(4) receptor, suggesting positive feedback regulation which may lead to accelerated catabolic processes in tendon fibroblasts. Studies using pathway-specific chemical inhibitors suggest that the p38 MAPK pathway is the key signaling cascade transducing IL-1beta-mediated catabolic effects. Collectively, our findings suggest that the EP(4) receptor mediates the IL-1beta-induced catabolic metabolism via the p38 MAPK pathway in human tendon fibroblasts and may play a major role in the tendon's degenerative changes often seen in the later stages of tendinopathy.

The Genotypes of IL-1 beta and MMP-3 are Associated with the Prognosis of HCV-related Hepatocellular Carcinoma

“…The distribution rates and allele frequencies in our study are similar to those from previous reports from Japan (9,11,17,34,35 (9,10,33) (4,5,36,37 …”

Tendon injury and repair – A perspective on the basic mechanisms of tendon disease and future clinical therapy

“…An immense body of scientific work has shown that connective tissue MMP gene expression is regulated by various cytokines and signaling molecules (most importantly TGF-b, IL-1b, TNF-a, and Wnt) [160][161][162][163][164][165] but it is only vaguely understood how these signal transduction pathways are initiated and then coordinated toward a successful tissue repair [152]. Substantial scientific research effort is required to enable better understanding of how these aspects contribute to tissue repair outcome.…”

International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

“…IL-1␤-induced up-regulation of COX-2 was ascribed to interaction of released PGE 2 with EP 4 receptors (Faour et al, 2001). IL-1␤ also increases PGE 2 production in human tendon fibroblasts, which mediates down-regulation of type 1 collagen via EP 4 receptors, which in turn may disturb tendon homeostasis (Thampatty et al, 2007).…”